Trial NCT02627430

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2015-02063
Secondary IDs: 9896 NCI-2015-02063 P30CA006516 UM1CA186709

Last trial update was posted on 2016-07-26

MeSH Interventions

Talazoparib

MeSH Conditions

Adenocarcinoma Breast Neoplasms Carcinoma Cystadenocarcinoma, Serous Neoplasms Neoplasms, Cystic, Mucinous, and Serous Recurrence Triple Negative Breast Neoplasms

Other Conditions

Adult Solid Neoplasm Estrogen Receptor Negative Fallopian Tube Serous Neoplasm HER2/Neu Negative Ovarian Serous Adenocarcinoma Ovarian Serous Tumor Primary Peritoneal Serous Adenocarcinoma Progesterone Receptor Negative Recurrent Breast Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Triple-Negative Breast Carcinoma

Stopping Reasons

Other - Protocol moved to Withdrawn

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID